The impact of preoperative benzodiazepine use on postoperative opioid use in total shoulder arthroplasty
Journal of Shoulder and Elbow Surgery · 2024
DOI: 10.1016/j.jse.2024.02.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Shoulder and Elbow Surgery, 2024. Verfasst von Dominic M Farronato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Benzodiazepines, Analgesics, Opioid, Arthroplasty, Replacement, Shoulder, Postoperative Pain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: As the rate of total shoulder arthroplasty (TSA) and preoperative benzodiazepine use rise, there is an increased need to understand the impact of preoperative benzodiazepine use on postoperative opioid consumption following TSA, especially amid the current opioid epidemic. The relationship between preoperative benzodiazepine use and chronic opioid use postoperatively has been well described following other orthopedic procedures; however, the impact on patients undergoing TSA remains unclear. This study aims to identify the impact of preoperative benzodiazepine use on opioid use following TSA. METHODS: A retrospective chart review of 4488 patients undergoing primary TSA (Current Procedural Terminology code 23472) at a single institution from 2014 to 2022 was performed. Patient demographics, surgical variables, comorbidities, Distressed Communities Index (DCI), and clinical outcomes, including readmission and revision, were collected. The Charlson Comorbidity Index (CCI) was used to assess preoperative health status. Opioid use in morphine milligram equivalents (MMEs) and benzodiazepine use were also recorded using the Prescription Drug Monitoring Program Database. Opioid use was collected at 30-, 60-, and 90-day intervals both before and after each patient's date of surgery. Statistical analysis included stepwise logistic regression to identify variables independently affecting benzodiazepine use pre- and postoperatively. RESULTS: Overall, 16% of patients used benzodiazepines within 90 days before their date of surgery. Of those patients, 46.4% were also using preoperative opioids, compared with just 30.0% of patients who were benzodiazepine-naïve (P 30 days after surgery) compared to 19.0% of those who were benzodiazepine-naïve (P < .001). CONCLUSION: This study demonstrates a significant association between preoperative benzodiazepine use and increased and prolonged opioid use following TSA. Further exploration of risk factors contributing to preoperative benzodiazepine use may help to reduce overall opioid use in patients undergoing TSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
- Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA, USA.
- Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: Daniel.Davis@rothmanortho.com.
Zitieren
APA
Farronato, D. M., Pezzulo, J. D., Paulik, J., Miltenberg, B., Johns, W. L., & Davis, D. E. (2024). The impact of preoperative benzodiazepine use on postoperative opioid use in total shoulder arthroplasty. Journal of Shoulder and Elbow Surgery. https://doi.org/10.1016/j.jse.2024.02.021
Vancouver
Farronato DM, Pezzulo JD, Paulik J, Miltenberg B, Johns WL, Davis DE. The impact of preoperative benzodiazepine use on postoperative opioid use in total shoulder arthroplasty. Journal of Shoulder and Elbow Surgery. 2024. doi:10.1016/j.jse.2024.02.021
BibTeX
@article{Farronato2024,
author = {Farronato, Dominic M and Pezzulo, Joshua D and Paulik, John and Miltenberg, Benjamin and Johns, William L and Davis, Daniel E},
title = {The impact of preoperative benzodiazepine use on postoperative opioid use in total shoulder arthroplasty},
journal = {Journal of Shoulder and Elbow Surgery},
year = {2024},
doi = {10.1016/j.jse.2024.02.021}
}
EUVIMED